Lupron Depot-PED

AbbVie Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 14, 2025
Approval ID: e99f47d2-da10-3127-ecb3-e5d942ae6e81
Products: 6 registered
Version: 90

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LUPRON DEPOT-PED safely and effectively. See full prescribing information for LUPRON DEPOT-PED. LUPRON DEPOT-PED (leuprolide acetate for depot suspension) , for intramuscular use Initial U.S. Approval: 1985

Quick Stats

Total Products6

Labelers2

Label Sections41

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.